JY
CLPT icon

Jeff Yass’s ClearPoint Neuro CLPT Stock Holding History

Jeff Yass’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.29M Buy
240,282
+103,998
+76% +$1.3M ﹤0.01% 4929
2026
Q1 		$1.24M Sell
136,284
-14,272
-9% -$180K ﹤0.01% 7336
2025
Q4 		$2.06M Buy
+150,556
New +$2.79M ﹤0.01% 5601
2025
Q3 		– Sell
-75,607
Closed -$891K – 12560
2025
Q2 		$903K Sell
75,607
-406,765
-84% -$5.12M ﹤0.01% 7701
2025
Q1 		$5.74M Sell
482,372
-26,792
-5% -$417K ﹤0.01% 3394
2024
Q4 		$7.83M Buy
509,164
+358,189
+237% +$4.64M ﹤0.01% 2957
2024
Q3 		$1.69M Buy
150,975
+76,408
+102% +$732K ﹤0.01% 5621
2024
Q2 		$402K Buy
74,567
+49,634
+199% +$287K ﹤0.01% 8784
2024
Q1 		$170K Buy
24,933
+7,270
+41% +$50.8K ﹤0.01% 10781
2023
Q4 		$120K Buy
+17,663
New +$100K ﹤0.01% 11179
2023
Q3 		– Sell
-23,425
Closed -$139K – 12104
2023
Q2 		$170K Sell
23,425
-124,222
-84% -$1.06M ﹤0.01% 10449
2023
Q1 		$1.25M Buy
147,647
+19,075
+15% +$167K ﹤0.01% 6250
2022
Q4 		$1.09M Buy
128,572
+103,974
+423% +$985K ﹤0.01% 5997
2022
Q3 		$255K Buy
+24,598
New +$324K ﹤0.01% 10220
2022
Q2 		– Sell
-22,152
Closed -$226K – 12988
2022
Q1 		$231K Sell
22,152
-40,783
-65% -$371K ﹤0.01% 10890
2021
Q4 		$706K Sell
62,935
-12,235
-16% -$183K ﹤0.01% 8232
2021
Q3 		$1.33M Sell
75,170
-42,012
-36% -$788K ﹤0.01% 6800
2021
Q2 		$2.24M Buy
117,182
+27,427
+31% +$530K ﹤0.01% 5662
2021
Q1 		$1.9M Buy
+89,755
New +$1.92M ﹤0.01% 6053

Other funds holding CLPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
CFM
Compass Financial Management Tampa, Florida $829M AUM

Jeff Yass's CLPT Position: Q2 2026 in Review

Jeff Yass increased its ClearPoint Neuro (CLPT) stake by 76% in Q2 2026, buying an estimated $1.3M and bringing the position to 240,282 shares worth $4.29M. The position accounts for ﹤0.01% of the portfolio, ranked #4929.

Jeff Yass first reported a position in CLPT in Q1 2021 and has held it in 19 quarters since. The position peaked at $7.83M in Q4 2024. 129 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

  • Jeff Yass held 240,282 shares of ClearPoint Neuro worth $4.29M as of Q2 2026.
  • Jeff Yass bought 103,998 ClearPoint Neuro shares in Q2 2026, an estimated $1.3M.
  • ClearPoint Neuro made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #4929 holding.
  • Jeff Yass first reported a position in ClearPoint Neuro in Q1 2021 and has held it in 19 quarters since.
  • Jeff Yass's ClearPoint Neuro position peaked at $7.83M in Q4 2024.
  • 129 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.